RM-1929 photo-immunotherapy in patients with recurrent head and neck cancer: Results of a multicenter phase 2a open-label clinical trial.

Ann Marie Gillenwater,David Cognetti,Jennifer Johnson,Joseph Curry,Samith Thomas Kochuparambil,Darren McDonald,Mary J. Fidler,Kerstin M. Stenson,Nilesh Vasan,Mohammad Razaq,John Campana,Frank E. Mott,David Cognetti

RM-1929 photo-immunotherapy in patients with recurrent head and neck cancer: Results of a multicenter phase 2a open-label clinical trial.

2018

Ann Marie Gillenwater
David Cognetti
Jennifer Johnson
Joseph Curry
Samith Thomas Kochuparambil
Darren McDonald
Mary J. Fidler
Kerstin M. Stenson
Nilesh Vasan
Mohammad Razaq
John Campana
Frank E. Mott
David Cognetti

6039Background: Patients with recurrent HNSCC (rHNSCC) have limited therapeutic options and poor prognosis. We report promising results of a Phase 2a trial of photoimmunotherapy (PIT) for the treat...

Keywords:

Clinical trial
Physical therapy
Immunotherapy
Head and neck cancer
Medicine
open label
Photoimmunotherapy
Oncology
in patient
Internal medicine
poor prognosis

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations